180 related articles for article (PubMed ID: 25332216)
21. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N
J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613
[TBL] [Abstract][Full Text] [Related]
22. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.
Englund K; Blanck A; Gustavsson I; Lundkvist U; Sjöblom P; Norgren A; Lindblom B
J Clin Endocrinol Metab; 1998 Nov; 83(11):4092-6. PubMed ID: 9814497
[TBL] [Abstract][Full Text] [Related]
23. Bisphenol A Concentrates Preferentially in Human Uterine Leiomyoma and Induces Proliferation in Rat Myometrium.
Othman ER; Al-Adly DM; Elgamal DA; Ghandour N; El-Sharkawy S
Reprod Sci; 2016 Apr; 23(4):508-14. PubMed ID: 26445998
[TBL] [Abstract][Full Text] [Related]
24. Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture.
Azzopardi E; Boyce DE
Br J Hosp Med (Lond); 2012 Aug; 73(8):432-6. PubMed ID: 22875519
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
[TBL] [Abstract][Full Text] [Related]
26. Modelling fibroid pathology: development and manipulation of a myometrial smooth muscle cell macromolecular crowding model to alter extracellular matrix deposition.
Winter A; Salamonsen LA; Evans J
Mol Hum Reprod; 2020 Jul; 26(7):498-509. PubMed ID: 32449756
[TBL] [Abstract][Full Text] [Related]
27. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
[TBL] [Abstract][Full Text] [Related]
28. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
[TBL] [Abstract][Full Text] [Related]
29. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
[TBL] [Abstract][Full Text] [Related]
30. Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
Ko YA; Jamaluddin MFB; Adebayo M; Bajwa P; Scott RJ; Dharmarajan AM; Nahar P; Tanwar PS
Reproduction; 2018 Jan; 155(1):61-71. PubMed ID: 29066531
[TBL] [Abstract][Full Text] [Related]
31. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
32. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
[TBL] [Abstract][Full Text] [Related]
33. A modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie's disease results in reduced procedural morbidity using a standardized hematoma classification rubric.
Amighi A; Mills SA; Eleswarapu SV; Regets KV; Mendhiratta N; Mills JN
World J Urol; 2020 Feb; 38(2):293-298. PubMed ID: 31152197
[TBL] [Abstract][Full Text] [Related]
34. Origin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells.
Elkafas H; Qiwei Y; Al-Hendy A
Semin Reprod Med; 2017 Nov; 35(6):481-486. PubMed ID: 29100235
[No Abstract] [Full Text] [Related]
35. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.
Islam MS; Protic O; Ciavattini A; Giannubilo SR; Tranquilli AL; Catherino WH; Castellucci M; Ciarmela P
Fertil Steril; 2014 Aug; 102(2):597-606. PubMed ID: 24934492
[TBL] [Abstract][Full Text] [Related]
36. Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas.
Weir EC; Goad DL; Daifotis AG; Burtis WJ; Dreyer BE; Nowak RA
J Clin Endocrinol Metab; 1994 Mar; 78(3):784-9. PubMed ID: 8126157
[TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical analysis of fibroid vasculature.
Casey R; Rogers PA; Vollenhoven BJ
Hum Reprod; 2000 Jul; 15(7):1469-75. PubMed ID: 10875852
[TBL] [Abstract][Full Text] [Related]
38. Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond.
Mills SA; Gelbard MK
World J Urol; 2020 Feb; 38(2):269-277. PubMed ID: 31168744
[TBL] [Abstract][Full Text] [Related]
39. Differential Response to Mechanical Cues in Uterine Fibroid Versus Paired Myometrial Cells.
Schutte SC; Ghosh D; Moset Zupan A; Warwar R; Dawson MR
Reprod Sci; 2023 Nov; 30(11):3305-3314. PubMed ID: 37253935
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of Dupuytren's contracture by collagenase injection].
Foissac R; Camuzard O; Dumas P; Dumontier C; Chignon-Sicard B
Chir Main; 2013 Sep; 32(4):199-205. PubMed ID: 23856551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
